Clinical trial updates
What's being tested
right now.
Clinical trial updates
- ClinicalTrials.gov
- Official source
- 8
- Compounds tracked
- Updated
- Every rebuild
Clinical trial updates
Latest across all compounds
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT06274749
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
National Institute on Aging (NIA)
- Phase
- Phase n/a
- Status
- Recruiting
- Enrollment
- 180
- Est. completion
- Mar 31, 2027
NCT07840729
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Shanghai JMT-Bio Inc.
- Phase
- Phase 1
- Status
- Recruiting
- Enrollment
- 90
- Est. completion
- Apr 30, 2027
NCT07911046
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Erin Mauney
- Phase
- Phase n/a
- Status
- Not Yet Recruiting
- Enrollment
- 12
- Est. completion
- Jun 2029
NCT07906041
Tirzepatide and Organ-specific Biological Aging
Atria Research and Global Health Institute (ARGHI)
- Phase
- Phase 2
- Status
- Enrolling By Invitation
- Enrollment
- 22
- Est. completion
- Sep 2028
NCT07908940
Changes in Body Composition Following Pharmacological Treatment for Obesity.
Hospital San Carlos, Madrid
- Phase
- Phase n/a
- Status
- Enrolling By Invitation
- Enrollment
- 116
- Est. completion
- Dec 31, 2027
NCT04916470
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
Novo Nordisk A/S
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 617
- Est. completion
- Oct 11, 2023
NCT07909889
Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer
Aarhus University Hospital
- Phase
- Phase 2
- Status
- Not Yet Recruiting
- Enrollment
- 32
- Est. completion
- Sep 2029
NCT07846865
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea
Woolcock Institute of Medical Research
- Phase
- Phase 2 / Phase 3
- Status
- Not Yet Recruiting
- Enrollment
- 256
- Est. completion
- Dec 1, 2028
NCT07850050
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Boehringer Ingelheim
- Phase
- Phase 3
- Status
- Not Yet Recruiting
- Enrollment
- 600
- Est. completion
- Jul 26, 2028
NCT06700538
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Arrowhead Pharmaceuticals
- Phase
- Phase 1 / Phase 2
- Status
- Active Not Recruiting
- Enrollment
- 190
- Est. completion
- Feb 15, 2028
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Semaglutide
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT07840729
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Shanghai JMT-Bio Inc.
- Phase
- Phase 1
- Status
- Recruiting
- Enrollment
- 90
- Est. completion
- Apr 30, 2027
NCT07911046
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Erin Mauney
- Phase
- Phase n/a
- Status
- Not Yet Recruiting
- Enrollment
- 12
- Est. completion
- Jun 2029
NCT07908940
Changes in Body Composition Following Pharmacological Treatment for Obesity.
Hospital San Carlos, Madrid
- Phase
- Phase n/a
- Status
- Enrolling By Invitation
- Enrollment
- 116
- Est. completion
- Dec 31, 2027
NCT04916470
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
Novo Nordisk A/S
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 617
- Est. completion
- Oct 11, 2023
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Tirzepatide
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT07906041
Tirzepatide and Organ-specific Biological Aging
Atria Research and Global Health Institute (ARGHI)
- Phase
- Phase 2
- Status
- Enrolling By Invitation
- Enrollment
- 22
- Est. completion
- Sep 2028
NCT07908940
Changes in Body Composition Following Pharmacological Treatment for Obesity.
Hospital San Carlos, Madrid
- Phase
- Phase n/a
- Status
- Enrolling By Invitation
- Enrollment
- 116
- Est. completion
- Dec 31, 2027
NCT07846865
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea
Woolcock Institute of Medical Research
- Phase
- Phase 2 / Phase 3
- Status
- Not Yet Recruiting
- Enrollment
- 256
- Est. completion
- Dec 1, 2028
NCT06700538
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Arrowhead Pharmaceuticals
- Phase
- Phase 1 / Phase 2
- Status
- Active Not Recruiting
- Enrollment
- 190
- Est. completion
- Feb 15, 2028
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Retatrutide
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Eli Lilly and Company
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 4,500
- Est. completion
- Aug 2032
NCT06383390
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company
- Phase
- Phase 3
- Status
- Active Not Recruiting
- Enrollment
- 10,000
- Est. completion
- Feb 2029
NCT06982859
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
- Phase
- Phase 1
- Status
- Active Not Recruiting
- Enrollment
- 95
- Est. completion
- Jan 2027
NCT06260722
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Eli Lilly and Company
- Phase
- Phase 3
- Status
- Active Not Recruiting
- Enrollment
- 1,250
- Est. completion
- Feb 2027
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Survodutide
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT07850050
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Boehringer Ingelheim
- Phase
- Phase 3
- Status
- Not Yet Recruiting
- Enrollment
- 600
- Est. completion
- Jul 26, 2028
NCT07850063
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Boehringer Ingelheim
- Phase
- Phase 3
- Status
- Not Yet Recruiting
- Enrollment
- 600
- Est. completion
- Apr 29, 2029
NCT06077864
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Boehringer Ingelheim
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 5,530
- Est. completion
- Jun 30, 2026
NCT07754461
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Boehringer Ingelheim
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 600
- Est. completion
- May 1, 2028
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
CagriSema
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT07607587
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Novo Nordisk A/S
- Phase
- Phase 1
- Status
- Recruiting
- Enrollment
- 114
- Est. completion
- Nov 19, 2027
NCT07282613
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 80
- Est. completion
- Mar 30, 2030
NCT06534411
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Novo Nordisk A/S
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 1,023
- Est. completion
- Jul 9, 2026
NCT06221969
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Novo Nordisk A/S
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 1,024
- Est. completion
- Apr 6, 2026
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Urolithin A
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT06274749
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
National Institute on Aging (NIA)
- Phase
- Phase n/a
- Status
- Recruiting
- Enrollment
- 180
- Est. completion
- Mar 31, 2027
NCT06022822
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
National Cancer Institute (NCI)
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 90
- Est. completion
- May 1, 2028
NCT07377136
Influence of the Urolithin A on the Population With BMI Higher Than 30 During Restricted Eating.
Charles University, Czech Republic
- Phase
- Phase n/a
- Status
- Active Not Recruiting
- Enrollment
- 102
- Est. completion
- Feb 28, 2027
NCT07517913
Cerebrospinal Fluid Kinetics of Urolithin A
Amazentis SA
- Phase
- Phase n/a
- Status
- Completed
- Enrollment
- 40
- Est. completion
- Oct 4, 2026
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Elamipretide (SS-31)
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT04689360
An Intermediate Size Expanded Access Protocol of Elamipretide
Stealth BioTherapeutics Inc.
- Phase
- Phase n/a
- Status
- Available
- Enrollment
- —
- Est. completion
- —
NCT06373731
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Stealth BioTherapeutics Inc.
- Phase
- Phase 3
- Status
- Active Not Recruiting
- Enrollment
- 313
- Est. completion
- Sep 2027
NCT07531251
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
Stealth BioTherapeutics Inc.
- Phase
- Phase 4
- Status
- Recruiting
- Enrollment
- 48
- Est. completion
- Nov 30, 2029
NCT05168774
FRDA Investigator Initiated Study (IIS) With Elamipretide
Children's Hospital of Philadelphia
- Phase
- Phase 1 / Phase 2
- Status
- Completed
- Enrollment
- 20
- Est. completion
- Jul 25, 2024
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Clinical trial updates
Tesamorelin
Live from ClinicalTrials.gov. A registered trial describes a study plan — it does not show that an intervention is effective.
NCT03226821
Body Composition and Adipose Tissue in HIV
Columbia University
- Phase
- Phase 4
- Status
- Terminated
- Enrollment
- 6
- Est. completion
- Apr 30, 2025
NCT06554717
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Massachusetts General Hospital
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 100
- Est. completion
- Dec 1, 2028
NCT07481734
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Hudson Biotech
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 120
- Est. completion
- Feb 17, 2028
NCT02572323
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
University of California, San Diego
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 73
- Est. completion
- Oct 15, 2023
Source: ClinicalTrials.gov API v2 · Last synchronized Nov 3, 2026
Data from the ClinicalTrials.gov API, refreshed each time the site is rebuilt. Trial listings are not recommendations; registered studies may be paused, changed or never published.